Intel: What Are the Chances of a Restructuring and Who Are the Likely Benefactors?
Intel Corporation, Qualcomm Incorporated, VMware Inc, Broadcom Inc. Read The Tokenist (Timothy Fries)'s latest article on Investing.com ...
Intel Stock: Elemental Analysis Of An Acquisition (Rating Upgrade)
As long as the rumors of deal making remain in the news, Intel's stock should remain at materially higher levels than the 50 ...
'This is not unlocking shareholder value, it's a fire sale': Jim Keller weighs in on a possible 'careless' Intel chip and fab spin-off
If Keller's correct and a good Intel can make for a $1 trillion chipmaking company, then maybe it would be a little careless ...
Two major tech leaders consider shaking things up at Intel
A tech company that has struggled significantly over the past year may have an unexpected saving grace. Intel was once ranked ...
eVnExpress on MSN9h
Chance to engage with $1.5 trillion AI and semiconductor ecosystem at AISC 2025
The AI-Semiconductor Conference (AISC 2025) presents an opportunity for Vietnamese businesses and startups to integrate into the global AI and semiconductor ecosystem, valued in the trillions of ...
Fiiber on MSN13h
Microsoft's Majorana 1 chip could make a quantum computer more powerful than all current computers combined
Microsoft has unveiled its first quantum processor that uses Majorana particles instead of electrons, It is smaller than the palm of a hand and can scale up to a million qubits.
Business Times21h
Complex AI chips will drive demand for Lam Research chipmaking tools, CEO says
LAM Research chief executive Tim Archer said on Wednesday (Feb 19) that the thirst for complex artificial intelligence (AI) ...
Vontobel Holding Ltd. Trims Position in CRISPR Therapeutics AG (NASDAQ:CRSP)
Vontobel Holding Ltd. trimmed its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 11.1% during the 4th quarter, Holdings Channel.com reports. The firm owned 15,068 shares of the ...
HC Wainwright Forecasts Strong Price Appreciation for Stoke Therapeutics (NASDAQ:STOK) Stock
Stoke Therapeutics (NASDAQ:STOK – Get Free Report) had its target price raised by analysts at HC Wainwright from $35.00 to $47.00 in a research note issued on Tuesday,Benzinga reports. The firm ...